Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
UK malaria treatment guidelines 2016.
Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL; PHE Advisory Committee on Malaria Prevention in UK Travellers.
J Infect. 2016 Jun;72(6):635-649. doi: 10.1016/j.jinf.2016.02.001. Epub 2016 Feb 12.
Congenital toxoplasmosis.
Kieffer F, Wallon M.
Handb Clin Neurol. 2013;112:1099-101. doi: 10.1016/B978-0-444-52910-7.00028-3.
Hepatic Capillariasis- Drug Targets.
Dubey A, Bagchi A, Sharma D, Dey A, Nandy K, Sharma R.
Infect Disord Drug Targets. 2018;18(1):3-10. doi: 10.2174/1871526517666170427124254.
Leishmaniases: Strategies in treatment development.
Majoor A, Michel G, Marty P, Boyer L, Pomares C.
Parasite. 2025;32:18. doi: 10.1051/parasite/2025009. Epub 2025 Mar 5.
Delivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin-piperaquine with or without targeted information transfer or sulfadoxine-pyrimethamine in western Kenya: a three-armed, pragmatic, open-label, cluster-randomised trial.
Barsosio HC, Webster J, Omiti F, K'Oloo A, Odero IA, Ojuok MA, Odiwa D, Omondi B, Okello E, Dodd J, Taegtmeyer M, Kuile FOT, Lesosky M, Kariuki S, Hill J.
Lancet Glob Health. 2024 Oct;12(10):e1660-e1672. doi: 10.1016/S2214-109X(24)00261-4.
Malaria vaccines: facing unknowns.
Palacpac NMQ, Horii T.
F1000Res. 2020 Apr 27;9:F1000 Faculty Rev-296. doi: 10.12688/f1000research.22143.1. eCollection 2020.
Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis.
Van Gerwen OT, Craig-Kuhn MC, Jones AT, Schroeder JA, Deaver J, Buekens P, Kissinger PJ, Muzny CA.
BJOG. 2021 Nov;128(12):1907-1915. doi: 10.1111/1471-0528.16774. Epub 2021 Jun 27.
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Barsosio HC, Madanitsa M, Ondieki ED, Dodd J, Onyango ED, Otieno K, Wang D, Hill J, Mwapasa V, Phiri KS, Maleta K, Taegtmeyer M, Kariuki S, Schmiegelow C, Gutman JR, Ter Kuile FO.
Lancet. 2024 Jan 27;403(10424):365-378. doi: 10.1016/S0140-6736(23)02631-4. Epub 2024 Jan 12.
Lymphatic filariasis and onchocerciasis.
Taylor MJ, Hoerauf A, Bockarie M.
Lancet. 2010 Oct 2;376(9747):1175-85. doi: 10.1016/S0140-6736(10)60586-7. Epub 2010 Aug 23.
